Cargando…
The relationship between synaptic density marker SV2A, glutamate and N-acetyl aspartate levels in healthy volunteers and schizophrenia: a multimodal PET and magnetic resonance spectroscopy brain imaging study
Glutamatergic excitotoxicity is hypothesised to underlie synaptic loss in schizophrenia pathogenesis, but it is unknown whether synaptic markers are related to glutamatergic function in vivo. Additionally, it has been proposed that N-acetyl aspartate (NAA) levels reflect neuronal integrity. Here, we...
Autores principales: | Onwordi, Ellis Chika, Whitehurst, Thomas, Mansur, Ayla, Statton, Ben, Berry, Alaine, Quinlan, Marina, O’Regan, Declan P., Rogdaki, Maria, Marques, Tiago Reis, Rabiner, Eugenii A., Gunn, Roger N., Vernon, Anthony C., Natesan, Sridhar, Howes, Oliver D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8290006/ https://www.ncbi.nlm.nih.gov/pubmed/34282130 http://dx.doi.org/10.1038/s41398-021-01515-3 |
Ejemplares similares
-
O11.3. SYNAPTIC MARKER PROTEIN SV2A IS REDUCED IN SCHIZOPHRENIA IN VIVO AND UNAFFECTED BY ANTIPSYCHOTICS IN RATS
por: Chika Onwordi, Ellis, et al.
Publicado: (2020) -
Synaptic density marker SV2A is reduced in schizophrenia patients and unaffected by antipsychotics in rats
por: Onwordi, Ellis Chika, et al.
Publicado: (2020) -
The histamine system and cognitive function: An in vivo H3 receptor PET imaging study in healthy volunteers and patients with schizophrenia
por: Arumuham, Atheeshaan, et al.
Publicado: (2023) -
Cardiac structure and function in schizophrenia: cardiac magnetic resonance imaging study
por: Osimo, Emanuele F., et al.
Publicado: (2020) -
Cardiac structure and function in patients with schizophrenia taking antipsychotic drugs: an MRI study
por: Pillinger, Toby, et al.
Publicado: (2019)